Loading
NASDAQHealthcareMedical - Healthcare Information Services
Latest quote
$3.08
+$0.03 · +0.98%
LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.
Previous close
$3.08
+$0.03 · +0.98%
Regular session · ET · Market data may be delayed.
LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.
Day range
Current $3.08
52-week range
Current $3.08
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
53
Fair Value
Sentiment
67
Bullish
Risk
77
High Risk
Momentum
44
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.
Day range
Current $3.08
52-week range
Current $3.08
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 194.06M USD | 212.45M USD | 152.55M USD | 119.03M USD | 92.88M USD |
| Cost of goods sold | 39.29M USD | 24.07M USD | 18.9M USD | 18.67M USD | 18M USD |
| Gross profit | 154.76M USD | 188.39M USD | 133.65M USD | 100.37M USD | 74.88M USD |
| Research and development | 7.35M USD | 9.51M USD | 6.06M USD | 2.97M USD | 948.16K USD |
| Selling, general, and administrative | 144.01M USD | 175.68M USD | 128.15M USD | 125.33M USD | 122.08M USD |
| Operating expenses | 162.43M USD | 204.53M USD | 148.14M USD | 143.81M USD | 129.18M USD |
| Interest expense | 1.36M USD | 2.18M USD | 2.6M USD | 1.28M USD | 3.02M USD |
| Depreciation and amortization | 7.31M USD | 9.49M USD | 6.6M USD | 1.09M USD | 355.87K USD |
| Operating income | −7.67M USD | −16.14M USD | −14.49M USD | −43.45M USD | −54.3M USD |
| Net income | −7.11M USD | −18.88M USD | −20.6M USD | −45.54M USD | −60.9M USD |
Company facts updated Sep 7, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$7.67
149.03% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Oct 14, 2020 | 1:5 | — | — |
Effective Oct 14, 2020
1:5
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI4.29M0.00%2.3T USD0.03%$379.73-0.32%
iShares Russell 2000 ETFIWM3.13M0.00%80.51B USD0.19%$296.01+0.28%
Vanguard Extended Market ETFVXF1.66M0.00%93.7B USD0.05%$242.66+0.14%
State Street SPDR S&P Kensho New Economies Composite ETFKOMP1.61M0.06%2.67B USD0.20%$67.695+0.29%
iShares Russell 2000 Growth ETFIWO862.98K0.01%14.7B USD0.24%$377.54+0.12%
Vanguard Russell 2000 ETFVTWO780.84K0.00%17.4B USD0.06%$119.62+0.25%
iShares Micro-Cap ETFIWC411.88K0.03%1.49B USD0.60%$196.25+0.69%
iShares Russell 2000 Value ETFIWN248.47K0.00%14.61B USD0.24%$224.62+0.40%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFState Street SPDR S&P Kensho New Economies Composite ETFKOMPiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCiShares Russell 2000 Value ETFIWNAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
